News | August 04, 2021
NATCO Pharma transfers Lenalidomide ANDA to Arrow
Arrow is the marketing partner in US
Arrow is the marketing partner in US
Arch Pharma Labs has filed the application
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
The govt has rolled out three schemes for promoting the manufacture of API
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
The company is confident of commencing production at both Mahad and Chiplun units soon
State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
The company has reported PAT of Rs. 10.7 crore for Q1 FY22, higher by 23% YoY
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
Subscribe To Our Newsletter & Stay Updated
